This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Lorenza Rimassa
lorenzarimassa.bsky.social
did:plc:47eyg4sm7lvqbke5glkahofa
Milind Javle presents the results of #tinengotinib in patients with #CCA #BTC and #FGFR2 gene fusions previously treated with other FGFR inhibitors at #ESMO25
#ESMOAmbassadors @myesmo.bsky.social
2025-10-20T07:13:12.956Z